Cargando…

Authors’ Reply to Coste et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”

Detalles Bibliográficos
Autores principales:	Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584222/ https://www.ncbi.nlm.nih.gov/pubmed/31161455 http://dx.doi.org/10.1007/s40262-019-00780-2

Ejemplares similares

Authors’ Reply to Nicolas: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Lechat et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Yu et al.: “Levothyrox(®) New and Old Formulations: Are They Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, Didier, et al.
Publicado: (2019)

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
por: Concordet, Didier, et al.
Publicado: (2019)

Comment on “Levothyrox(®) New and Old Formulations: Are They Switchable for Millions of Patients?”
por: Munafo, Alain, et al.
Publicado: (2019)

Authors’ Reply to Krebs-Brown et al. Comment on: “Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, D., et al.
Publicado: (2019)

Biased computation of probability of target attainment for antimicrobial drugs
por: Toutain, Pierre‐Louis, et al.
Publicado: (2023)

Veterinary Medicine Needs New Green Antimicrobial Drugs
por: Toutain, Pierre-Louis, et al.
Publicado: (2016)

Comparison of the In vitro Activity of Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus Biofilms
por: Ferran, Aude A., et al.
Publicado: (2016)

Bacterial Species-Specific Activity of a Fluoroquinolone against Two Closely Related Pasteurellaceae with Similar MICs: Differential In Vitro Inoculum Effects and In Vivo Efficacies
por: Lhermie, Guillaume, et al.
Publicado: (2015)

En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach
por: Toutain, Pierre-Louis, et al.
Publicado: (2017)

Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice
por: Vasseur, Maleck V., et al.
Publicado: (2017)

Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model
por: Lallemand, Elodie Anne, et al.
Publicado: (2021)

In vitro Degradation of Antimicrobials during Use of Broth Microdilution Method Can Increase the Measured Minimal Inhibitory and Minimal Bactericidal Concentrations
por: Lallemand, Elodie A., et al.
Publicado: (2016)

Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus
por: Broussou, Diane C., et al.
Publicado: (2019)

Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Staphylococcus aureus Bacteria in a Hollow Fiber Infection Model
por: Broussou, Diane C., et al.
Publicado: (2018)

Implementing Precision Antimicrobial Therapy for the Treatment of Bovine Respiratory Disease: Current Limitations and Perspectives
por: Lhermie, Guillaume, et al.
Publicado: (2017)

A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients
por: Bousquet-Mélou, Alain, et al.
Publicado: (2021)

“De-Shrinking” EBEs: The Solution for Bayesian Therapeutic Drug Monitoring
por: Baklouti, Sarah, et al.
Publicado: (2022)

Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination
por: Cagnardi, Petra, et al.
Publicado: (2018)

A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation
por: Baklouti, Sarah, et al.
Publicado: (2023)

Comment on “In Vitro Effects of Bisphenol A β-D-Glucuronide (BPA-G) on Adipogenesis in Human and Murine Preadipocytes”
por: Gayrard, Véronique, et al.
Publicado: (2015)

Levers to Improve Antibiotic Treatment of Lambs via Drinking Water in Sheep Fattening Houses: The Example of the Sulfadimethoxine/Trimethoprim Combination
por: Ferran, Aude A., et al.
Publicado: (2020)

Destruction of Staphylococcus aureus biofilms by combining an antibiotic with subtilisin A or calcium gluconate
por: Liu, JingJing, et al.
Publicado: (2021)

High Bioavailability of Bisphenol A from Sublingual Exposure
por: Gayrard, Véronique, et al.
Publicado: (2013)

Interpreting Bisphenol A Absorption in the Canine Oral Cavity: Gayrard et al. Respond
por: Gayrard, Véronique, et al.
Publicado: (2013)

Population Pharmacokinetics of Intravenous Amoxicillin Combined With Clavulanic Acid in Healthy and Critically Ill Dogs
por: Vegas Cómitre, Maria D., et al.
Publicado: (2021)

The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination
por: Ferran, Aude A., et al.
Publicado: (2022)

Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over Decades
por: Gandia, Peggy, et al.
Publicado: (2023)

Prediction of human prenatal exposure to bisphenol A and bisphenol A glucuronide from an ovine semi-physiological toxicokinetic model
por: Gauderat, Glenn, et al.
Publicado: (2017)

Pharmacokinetic–pharmacodynamic cutoff values for benzylpenicillin in horses to support the establishment of clinical breakpoints for benzylpenicillin antimicrobial susceptibility testing in horses
por: Lallemand, Elodie A., et al.
Publicado: (2023)

Prediction of Minocycline Activity in the Gut From a Pig Preclinical Model Using a Pharmacokinetic -Pharmacodynamic Approach
por: Vallé, Quentin, et al.
Publicado: (2021)

Authors' reply
por: Baud, David, et al.
Publicado: (2020)

VetCAST Method for Determination of the Pharmacokinetic-Pharmacodynamic Cut-Off Values of a Long-Acting Formulation of Florfenicol to Support Clinical Breakpoints for Florfenicol Antimicrobial Susceptibility Testing in Cattle
por: Toutain, Pierre-Louis, et al.
Publicado: (2019)

Towards a Better and Harmonized Education in Antimicrobial Stewardship in European Veterinary Curricula
por: Espinosa-Gongora, Carmen, et al.
Publicado: (2021)

Rational dosage regimens for cephalothin and cefazolin using pharmacokinetics and pharmacodynamics analysis in healthy horses
por: Kuroda, Taisuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m0q6ohplqvcsj7htrntng2cdlb